Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients
NCT ID: NCT05176652
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-12-06
2022-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optic Nerve Sheath Diameter in Preeclampsia
NCT04004897
Optic Nerve Sheath Diameter for Volume Status Prediction in Severe Preeclampsia
NCT04367519
Assessment of Optic Nerve Sheath Diameter in Preeclamptic Pregnant Women Using Ultrasonography and Anesthetic Management
NCT06522295
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.
NCT05594056
Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients
NCT03210350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
ultrasonographic assessment of optic nerve sheath diameter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proteinuria ≥5g in a 24 hour urine specimen or ≥3+ on 2 random urine samples collected at least 4 hours apart.
* patient acceptance
* Accepted mental state of the patients
Exclusion Criteria
* chronic kidney disease
* chronic pulmonary disease
* chronic cardiac disease
* chronic hypertension
* previous ocular operation and diseases
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hossam Eldin Hassan Ahmed
assisstant lecturer of anesthesia and ICU ,faculty of medicine at sohag university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hossam Eldin Hassan Ahmed Abdelghani
Sohag, , Egypt
Hossam Eldin Hassan Ahmed Abdelghani
Sohag, , Egypt
Hossam Eldin Hassan Ahmed Abdelghani
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-21-12-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.